Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin Maintenance in Hepatitis C Recurrence Post-Transplant
NCT00151580Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Feb 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatitis C (HCV) comparing Ribavirin Maintenance with Placebo Maintenance (2 arms). Primary endpoint: Negative viral PCR at 30 months. Started Feb 2002; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00151580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151580.